123 related articles for article (PubMed ID: 22455948)
1. Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis.
Zhao Z; Ge J; Sun Y; Tian L; Lu J; Liu M; Zhao Y
Oral Oncol; 2012 Sep; 48(9):761-7. PubMed ID: 22455948
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck.
Tandon S; Tudur-Smith C; Riley RD; Boyd MT; Jones TM
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):574-87. PubMed ID: 20142252
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis.
Fan Z; Li M; Chen X; Wang J; Liang X; Wang H; Wang Z; Cheng B; Xia J
Sci Rep; 2017 Feb; 7():43008. PubMed ID: 28220856
[TBL] [Abstract][Full Text] [Related]
4. Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer.
Hu Z; Qian G; Müller S; Xu J; Saba NF; Kim S; Chen Z; Jiang N; Wang D; Zhang H; Lane K; Hoyt C; Shin DM; Chen ZG
Oncotarget; 2016 Jul; 7(28):44676-44685. PubMed ID: 27172790
[TBL] [Abstract][Full Text] [Related]
5. The Role of E-Cadherin as a Prognostic Biomarker in Head and Neck Squamous Carcinoma: A Systematic Review and Meta-Analysis.
Yazdani J; Ghavimi MA; Jabbari Hagh E; Ahmadpour F
Mol Diagn Ther; 2018 Oct; 22(5):523-535. PubMed ID: 30006812
[TBL] [Abstract][Full Text] [Related]
6. mTOR pathway protein immunoexpression as a prognostic factor for survival in head and neck cancer patients: a systematic review and meta-analysis.
Marques AE; Elias ST; Porporatti AL; Castilho RM; Squarize CH; De Luca Canto G; Guerra EN
J Oral Pathol Med; 2016 May; 45(5):319-28. PubMed ID: 26661562
[TBL] [Abstract][Full Text] [Related]
7. Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study.
Cho JK; Kim MW; Choi IS; Moon UY; Kim MJ; Sohn I; Kim S; Jeong HS
BMC Cancer; 2018 Oct; 18(1):969. PubMed ID: 30309318
[TBL] [Abstract][Full Text] [Related]
8. Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis.
Keren S; Shoude Z; Lu Z; Beibei Y
Tumour Biol; 2014 Mar; 35(3):2285-95. PubMed ID: 24234257
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
10. Slug is a key mediator of hypoxia induced cadherin switch in HNSCC: correlations with poor prognosis.
Zhang J; Cheng Q; Zhou Y; Wang Y; Chen X
Oral Oncol; 2013 Nov; 49(11):1043-50. PubMed ID: 24035721
[TBL] [Abstract][Full Text] [Related]
11. Sex determining region Y-box 2 is a prognostic factor for head and neck squamous cell carcinoma: Evidence from 11 published investigations.
Li B; Chen M; Pan MX
J Cancer Res Ther; 2020; 16(3):434-439. PubMed ID: 32719247
[TBL] [Abstract][Full Text] [Related]
12. N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition.
Nguyen PT; Kudo Y; Yoshida M; Kamata N; Ogawa I; Takata T
Histol Histopathol; 2011 Feb; 26(2):147-56. PubMed ID: 21154228
[TBL] [Abstract][Full Text] [Related]
13. The impact of E-cadherin expression on the prognosis of esophageal cancer: a meta-analysis.
Xu XL; Ling ZQ; Chen SZ; Li B; Ji WH; Mao WM
Dis Esophagus; 2014 Jan; 27(1):79-86. PubMed ID: 23317312
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Jamali Z; Asl Aminabadi N; Attaran R; Pournagiazar F; Ghertasi Oskouei S; Ahmadpour F
Oral Oncol; 2015 Apr; 51(4):321-31. PubMed ID: 25677760
[TBL] [Abstract][Full Text] [Related]
15. Perineural invasion as a prognostic factor in head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Zhu J; Zhou R; Wang Y; Yu M
Acta Otolaryngol; 2019 Nov; 139(11):1038-1043. PubMed ID: 31464544
[No Abstract] [Full Text] [Related]
16. E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome.
Mattijssen V; Peters HM; Schalkwijk L; Manni JJ; van 't Hof-Grootenboer B; de Mulder PH; Ruiter DJ
Int J Cancer; 1993 Oct; 55(4):580-5. PubMed ID: 8406985
[TBL] [Abstract][Full Text] [Related]
17. "Is immuno-expression of E-cadherin really a prognostic factor in head and neck cancer?".
Dayan D; Vered M
Oral Oncol; 2013 Mar; 49(3):e5. PubMed ID: 23141905
[No Abstract] [Full Text] [Related]
18. The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.
Zhou LQ; Hu Y; Xiao HJ
BMC Cancer; 2021 Apr; 21(1):424. PubMed ID: 33863308
[TBL] [Abstract][Full Text] [Related]
19. ERCC1 plays an important role in predicting survival outcomes and treatment response for patients with HNSCC: a meta-analysis.
Xuelei M; Jingwen H; Wei D; Hongyu Z; Jing Z; Changle S; Lei L
Oral Oncol; 2015 May; 51(5):483-92. PubMed ID: 25754170
[TBL] [Abstract][Full Text] [Related]
20. Association of reduced immunohistochemical expression of E-cadherin with a poor ovarian cancer prognosis--results of a meta-analysis.
Peng HL; He L; Zhao X
Asian Pac J Cancer Prev; 2012; 13(5):2003-7. PubMed ID: 22901162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
